Chinese Journal of Pharmacovigilance ›› 2025, Vol. 22 ›› Issue (10): 1183-1187.
DOI: 10.19803/j.1672-8629.20250248

Previous Articles     Next Articles

Advances in Pharmacological Research on Oligoasthenozoospermia

TANG Tian1,2, TAN Tianyang3, LIU Zhejun4, BAI Xue1,*   

  1. 1Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Disease, Beijing 100700, China;
    2Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China;
    3Rehabilitation Medicine Department, Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing 100091, China;
    4School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China
  • Received:2025-04-22 Online:2025-10-15 Published:2025-10-20

Abstract: Objective To summarize the recent research advances in the mechanisms of action and therapeutic effects of drugs for oligoasthenospermia in combination with research findings from corresponding animal models in order to provide more targeted references for the selection of drugs, in-depth studies on mechanisms, and development of new drugs for prevention and treatment of oligoasthenospermia. Methods PubMed, CNKI, and other databases were searched particularly for literature on research progress in antioxidant stress drugs, anti-apoptosis drugs, metabolism-regulating drugs, targeted drugs, hormone-regulating drugs, and multi-target regulatory drugs of TCM using oligoasthenospermia models. The action of and research data on a range of drugs were elaborated. Results Antioxidant stress, anti-apoptosis, metabolism-regulating, targeted, hormone-regulating drugs, and multi-target regulatory drugs of TCM could all deliver distinct therapeutic effects. Some of these drugs were unusually effective at addressing critical pathological abnormalities such as oxidative stress, mitochondrial dysfunction, and apoptotic imbalance, thus significantly enhancing sperm quality. Conclusion More effort should be made to gain insights into the action mechanisms of drugs, promote the transition of more efficient and safe drugs from basic research to clinical applications in order to facilitate the prevention and treatment of oligoasthenospermia.

Key words: Oligoasthenospermia, Antioxidant Stress Drugs, Anti-Apoptosis Drugs, Sperm, Drug, Progress

CLC Number: